Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
Neuromuscular Disorders : NMD
|
November 28, 2012
Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseases
M Mancuso, C Angelini, E Bertini, et al.
Minerva Anestesiologica
|
February 20, 2013
Recommendations for anesthesia and perioperative management of patients with neuromuscular disorders
F Racca, T Mongini, A Wolfler, et al.
Human Mutation
|
October 15, 2008
Transcriptional behavior of DMD gene duplications in DMD/BMD males
F Gualandi, M Neri, M Bovolenta, et al.
Journal of Neurology
|
July 14, 2021
Adult-onset mitochondrial movement disorders: a national picture from the Italian Network
V Montano, D Orsucci, V Carelli, et al.
European Journal of Neurology
|
April 9, 2010
Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases
V A Sansone, M Panzeri, M Montanari, et al.
Journal of Neurology
|
November 15, 2011
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years
C Angelini, C Semplicini, S Ravaglia, et al.
Neuromuscular Disorders : NMD
|
April 17, 2007
The Hammersmith functional score correlates with the SMN2 copy number: a multicentric study
F D Tiziano, E Bertini, S Messina, et al.
Journal of Neurology
|
July 11, 2025
Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15 years of therapy with alglucosidase alfa
T Mongini, G Gadaleta, P Alonge, et al.
Neuromuscular Disorders : NMD
|
June 26, 2012
Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency
M Pane, S Messina, G Vasco, et al.
Neuropathology and Applied Neurobiology
|
June 3, 2017
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD)
M Ripolone, R Violano, D Ronchi, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
Neuromuscular Disorders : NMD
|
November 28, 2012
Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseases
M Mancuso, C Angelini, E Bertini, et al.
Minerva Anestesiologica
|
February 20, 2013
Recommendations for anesthesia and perioperative management of patients with neuromuscular disorders
F Racca, T Mongini, A Wolfler, et al.
Human Mutation
|
October 15, 2008
Transcriptional behavior of DMD gene duplications in DMD/BMD males
F Gualandi, M Neri, M Bovolenta, et al.
Journal of Neurology
|
July 14, 2021
Adult-onset mitochondrial movement disorders: a national picture from the Italian Network
V Montano, D Orsucci, V Carelli, et al.
European Journal of Neurology
|
April 9, 2010
Italian validation of INQoL, a quality of life questionnaire for adults with muscle diseases
V A Sansone, M Panzeri, M Montanari, et al.
Journal of Neurology
|
November 15, 2011
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years
C Angelini, C Semplicini, S Ravaglia, et al.
Neuromuscular Disorders : NMD
|
April 17, 2007
The Hammersmith functional score correlates with the SMN2 copy number: a multicentric study
F D Tiziano, E Bertini, S Messina, et al.
Journal of Neurology
|
July 11, 2025
Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15 years of therapy with alglucosidase alfa
T Mongini, G Gadaleta, P Alonge, et al.
Neuromuscular Disorders : NMD
|
June 26, 2012
Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency
M Pane, S Messina, G Vasco, et al.
Neuropathology and Applied Neurobiology
|
June 3, 2017
Effects of short-to-long term enzyme replacement therapy (ERT) on skeletal muscle tissue in late onset Pompe disease (LOPD)
M Ripolone, R Violano, D Ronchi, et al.
Page
of 9